Kodiak Sciences

Youtube Subscribe

Open: 9.23 Close: 9.0 Change: -0.23

10 things an AI found about Kodiak Sciences that you should know before investing.

The game is changing. There is a new strategy to evaluate Kodiak Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Kodiak Sciences are: Kodiak, Inc, share, Sciences, report, loss, earnings, …

Concept Map

Semantic Network

Stock Summary

Kodiak Sciences Inc. researches, develops, and commercializes therapeutics to treat retinal diseases. Kodiak sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. Its lead product candidate is tarcoc.

Today's Summary

Kodiak Sciences Inc. reported first-quarter 2023 loss per share of $1.35, wider than the Zacks Consensus Estimate of $ 1.28. Kodiak Science Inc. had cash, cash equivalents and marketable securities worth $421.2 million compared with $478.9 million as of Dec 31, 2023. Kodiaks Science Inc.s stock price per share is $9.00 today.

Today's News

Kodiak Sciences Inc. reported first-quarter 2023 loss per share of $1.35, wider than the Zacks Consensus Estimate of a loss of $ 1.28. The company last posted its earnings results on Tuesday, March 28th, and expects to post -5.06 earnings per share for the current fiscal year. Kodiak Sciences Inc. reported first-quarter 2023 loss per share of $1.35, wider than the Zacks Consensus Estimate of $ 1.28. Kodiak Science Inc. had cash, cash equivalents and marketable securities worth $421.2 million compared with $478.9 million as of Dec 31, 2023. Kodiak Sciences Inc. (KOD) shares are Up 26% in a week after the company announced remaining on track with ongoing studies in its fourth-quarter and full-year 2022 earnings report. Kodiak Sciencess stock price per share is $9.00 today (as of Jun 16, 2023) Kodiak Science Inc. stock was originally listed at a price of $10.16 in Oct. 2014 , that explainsership VII raging warmth couponMand Dag shelves 252

Stock Profile

"Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California."

Keywords

Are looking for the most relevant information about Kodiak Sciences? Investor spend a lot of time searching for information to make investment decisions in Kodiak Sciences. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Kodiak Sciences are: Kodiak, Inc, share, Sciences, report, loss, earnings, and the most common words in the summary are: kodiak, science, inc, market, advisor, alaska, program, . One of the sentences in the summary was: Kodiaks Science Inc.s stock price per share is $9.00 today.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #kodiak #science #inc #market #advisor #alaska #program.

Read more →

Youtube Subscribe

---